Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Mar 9;14:745–760. doi: 10.2147/JIR.S297166

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2021 Wang et al.

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).

PMC Copyright notice

The molecular structure of engeletin and the effects of engeletin on chondrocyte viability. (A) The molecular structure of engeletin. (B, C) Chondrocytes were treated with DMSO or different concentrations of engeletin (5, 10, 20, 40, 80 and 160 μM) for 24 (B) or 48 (C) hours. Then, cell viability was measured by CCK-8 assay. (D) Chondrocytes were treated with DMSO or different concentrations of engeletin (240, 320, 400, 480, 560, 640, 720, 800, 880 μM) for 24 hours to determine the toxicity of engeletin. The data are presented as the mean ± SD. n=3. ns: not significant.